Whole Shine Medical Technology Co., Ltd., located in Chaoyang, is an important research and production base for permanent magnet low-voltage electrical switch products in China. The company is primarily engaged in the research, production, and sales of permanent magnet switches and complete sets of high and low-voltage switch equipment. They offer a wide range of products, including high and low-voltage permanent magnet circuit breakers, contactors, complete sets of high and low-voltage equipment, as well as detection, control, and comprehensive protection products. In December 12, 2022, the company changed its Chinese name from "Rongyu Group Co., Ltd." to "Haochen Medical Technology Co., Ltd."
Basic Information
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
23.81%
Purchase this report to view the information.
3.84%
Purchase this report to view the information.
2.5%
Purchase this report to view the information.
1.79%
Purchase this report to view the information.
1.65%
Subsidiaries
Beijing Lulu Ba Technology Co., Ltd.
100%
Beijing Rongyu Technology Co., Ltd.
100%
Beijing Rui Chi Anxin Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Whole Shine Medical Technology Co.,Ltd. report is purchased.
Looking for more than just a company report?
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
27.43%▲
Total operating revenue
26.79%▲
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Operating Profit Margin (ROS)
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-4.48%▼
